Vaccination against Lyme disease caused by diverse Borrelia burgdorferi

doi:10.1084/jem.181.1.215

This Article

	Full Text (PDF)
	Alert me when this article is cited

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Fikrig, E.
	Articles by Spielman, A.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Fikrig, E.
	Articles by Spielman, A.


Social Bookmarking

	What's this?

ARTICLES

Vaccination against Lyme disease caused by diverse Borrelia burgdorferi

E Fikrig, SR Telford 3rd, R Wallich, M Chen, Y Lobet, FR Matuschka, RB Kimsey, FS Kantor, SW Barthold and A Spielman
Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut 06520.

Diversity and mutations in the genes for outer surface proteins (Osps) A and B of Borrelia burgdorferi sensu lato (B. burgdorferi), the spirochetal agent of Lyme disease, suggests that a monovalent OspA or OspB vaccine may not provide protection against antigenically variable naturally occurring B. burgdorferi. We now show that OspA or OspB immunizations protect mice from tick-borne infection with heterogeneous B. burgdorferi from different geographic regions. This result is in distinct contrast to in vitro killing analyses and in vivo protection studies using syringe injections of B. burgdorferi as the challenge inoculum. Evaluations of vaccine efficacy against Lyme disease and other vector-borne infections should use the natural mode of transmission and not be predicated on classification systems or assays that do not rely upon the vector to transmit infection.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to Technorati Technorati What's this?

This article has been cited by other articles:

Becker, M., Bunikis, J., Lade, B. D., Dunn, J. J., Barbour, A. G., Lawson, C. L. (2005). Structural Investigation of Borrelia burgdorferi OspB, a BactericidalFab Target. J. Biol. Chem. 280: 17363-17370 [Abstract] [Full Text]
Wang, G., van Dam, A. P., Schwartz, I., Dankert, J. (1999). Molecular Typing of Borrelia burgdorferi Sensu Lato: Taxonomic, Epidemiological, and Clinical Implications. Clin. Microbiol. Rev. 12: 633-653 [Abstract] [Full Text]
Bunikis, J., Barbour, A. G. (1999). Access of Antibody or Trypsin to an Integral Outer Membrane Protein (P66) of Borrelia burgdorferi Is Hindered by Osp Lipoproteins. Infect. Immun. 67: 2874-2883 [Abstract] [Full Text]
Sigal, L. H., Zahradnik, J. M., Lavin, P., Patella, S. J., Bryant, G., Haselby, R., Hilton, E., Kunkel, M., Adler-Klein, D., Doherty, T., Evans, J., Malawista, S. E., Molloy, P. J., Seidner, A. L., Sabetta, J. R., Simon, H. J., Klempner, M. S., Mays, J., Marks, D. (1998). A Vaccine Consisting of Recombinant Borrelia burgdorferi Outer-Surface Protein A to Prevent Lyme Disease. NEJM 339: 216-222 [Abstract] [Full Text]